News
Federal pharmacy prescribing trial expands despite GP concerns
The UTI and oral contraception pilot, originally limited to concession card holders, will expand to all women from January.
‘We haven’t been able to find evidence that shows that expanding prescribing to contraceptives is safe, easy, or necessary,’ says RACGP President Dr Michael Wright.
All women will have access to pharmacy prescribed UTI treatments and contraception from next year, with the Federal Government announcing a planned pharmacy trial for concession card holders will be expanded to all women.
It comes just seven months after the Federal Government announced that, under the 12-month pilot, all concession card holders will be able to access pharmacy treatment for uncomplicated UTIs and initiation or re-supply of hormonal contraception.
But under the expanded pilot, due to begin in January, the Federal Government said about 900,000 women now stood to benefit from the expanded access, according to their relevant state or territory rules, without the need to see a GP.
Monday’s announcement has drawn concern from the RACGP President Dr Michael Wright, who says the Government is ‘putting politics ahead of patient safety’.
‘We’re increasingly worried about women being the subject of these pilots,’ he told newsGP.
‘Women’s health is not a pilot project, and it looks like these decisions are putting politics ahead of patient safety and ahead of the evidence.’
Dr Wright said the RACGP had asked the Federal Government to undertake a ‘rigorous evaluation’ of the pilot, so it is ‘concerning’ the program is being expanded before any evaluation has occurred.
‘We don’t know what the rationale is to why the trial has been broadened, and it’s concerning that it’s happening even before the pilot’s got results,’ he said.
‘We’ve been looking for the evidence to support this and in the broad evidence reviews, we haven’t been able to find evidence that shows that expanding prescribing to contraceptives is safe, easy, or necessary.’
Federal Health and Ageing Minister Mark Butler said the Government wants to ‘make it easier for women to get care that fits into their lives’.
‘This trial is part of our Government’s promise to give Australian women more choice and control over their health, which has already benefited more than one million women,’ he said.
But Dr Wright’s concerns are echoed by women’s health expert Professor Danielle Mazza, who told newsGP the Government’s policy ‘is running way ahead of where the evidence sits’.
She said the announcement highlights two key issues – the absence of data on the safety and quality of pharmacy initiated prescribing of contraception, and the potential impact on women’s uptake of more reliable long-acting reversible contraception (LARC).
‘We have no rigorous data in the Australian context of the quality and safety outcomes of pharmacy initiated prescribing of contraception,’ Professor Mazza said.
‘So this policy is running way ahead of where the evidence sits in our context, which is very problematic because we don’t know what the outcomes will be, and contraception can be quite complex.’
Professor Mazza said the expansion is also a ‘contradiction’ to the Federal Government’s investment in improving the uptake of LARC in Australia; with pharmacy unable to prescribe products such as IUDs and implants, some women may choose oral contraception despite it not being their best option.
‘The marketing media that goes alongside this is “you don’t need to see your GP to get contraception. You can just go to a pharmacist”,’ she said.
‘Then, if they can’t receive their preferred contraception from the pharmacist, if their preferred contraception is an IUD or an implant, they may settle on just getting what they can get on the spot, which is the oral contraceptive pill.’
Dr Wright said college members and female patients had expressed their concerns to him about ‘the potential for fragmentation and side effects’ from pharmacy prescribing.
‘We really want women to be able to access safe, high-quality care and not deal with fragmentation, and certainly not be left with options that are less than best evidence,’ he said.
Pharmacy Guild of Australia National President Professor Trent Twomey said the decision provides women more choice in when and where they can access safe and affordable primary healthcare.
‘The trial will build on years of specially trained pharmacists delivering these services safely to patients across Australia and the world,’ he said.
‘Already, every month, more than 8000 Australian women visit a community pharmacy for the treatment of uncomplicated UTIs. Thousands more, think pharmacy first for hormonal contraception initiation and resupply.’
Log in below to join the conversation.
contraceptive fragmented care LARC pharmacy prescribing pilot program scope of practice UTI
newsGP weekly poll
In the past five years, have you experienced or observed sexism, misogyny, or gender bias from patients towards female or non-binary GPs?